(Q39465369)

12 September 2017

title

Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance (English)

1 reference

12 September 2017

1 reference

1 reference

lymphoblastic leukemia

1 reference

14

1 reference

12 September 2017

5

Lorraine Clark

1 reference

12 September 2017

Gopeshwar Narayan

1

1 reference

12 September 2017

Allen J Freddy

2

1 reference

12 September 2017

Dongxu Xie

3

1 reference

12 September 2017

Hema Liyanage

4

1 reference

12 September 2017

Sergey Kisselev

6

1 reference

12 September 2017

Ji Un Kang

7

1 reference

12 September 2017

Subhadra V Nandula

8

1 reference

12 September 2017

Catherine McGuinn

9

1 reference

12 September 2017

Shivakumar Subramaniyam

10

1 reference

12 September 2017

Bachir Alobeid

11

1 reference

12 September 2017

Prakash Satwani

12

1 reference

12 September 2017

David Savage

13

1 reference

12 September 2017

Vundavalli V Murty

15

1 reference

12 September 2017

publication date

24 August 2011

1 reference

Genes, Chromosomes and Cancer

12 September 2017

published in

1 reference

12 September 2017

volume

50

1 reference

12 September 2017

issue

12

1 reference

12 September 2017

page(s)

1043-1053

1 reference

Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer

12 September 2017

cites work

1 reference

Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cells

21 January 2018

1 reference

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

21 January 2018

1 reference

21 January 2018

1 reference

Epigenetics of acute lymphocytic leukemia

21 January 2018

1 reference

Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers

21 January 2018

1 reference

Cadherins and cancer: how does cadherin dysfunction promote tumor progression?

21 January 2018

1 reference

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia

21 January 2018

1 reference

MLL translocations, histone modifications and leukaemia stem-cell development

21 January 2018

1 reference

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)

21 January 2018

1 reference

Cytogenetics in acute leukemia

21 January 2018

1 reference

Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.

21 January 2018

1 reference

Global genomic characterization of acute lymphoblastic leukemia

21 January 2018

1 reference

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.

21 January 2018

1 reference

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

21 January 2018

1 reference

Differentiation therapy of leukemia: 3 decades of development

21 January 2018

1 reference

Decitabine--bedside to bench

21 January 2018

1 reference

Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas

21 January 2018

1 reference

Clustered protocadherin family

21 January 2018

1 reference

Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

21 January 2018

1 reference

Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies

21 January 2018

1 reference

PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer

21 January 2018

1 reference

Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/GCC.20922

1 reference

release_frzufk3jvfaoppqxg4frkinao4

12 September 2017

Fatcat ID

0 references

1 reference